Evidence map›Paper›PMID 30113451›Full record

ArticleMedicine2018

The utility of FDG-PET/CT imaging in the evaluation of multicentric reticulohistiocytosis: A case report.

Tomoyuki Asano, Ken Suzutani, Aya Watanabe, Aki Honda, Natsumi Mori, Makiko Yashiro, Shuzo Sato, Hiroko Kobayashi, Hiroshi Watanabe, Momoko Hazama and 4 more

Erratum issuedOpen access · goldAbstract readCase Reports
In one paragraph

Article in Medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Tomoyuki AsanoDepartment of Rheumatology Department of Dermatology, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima Department of Rheumatology, Ohta Nishinouchi General Hospital Foundation, Nishinouchi, Koriyama Department of Radiology, Fukushima Medical University School of Medicine, Hikarigaoka, Fukushima, Fukushima, Japan.
Ken Suzutani
Aya Watanabe
Aki Honda
Natsumi Mori
Makiko Yashiro
Shuzo Sato
Hiroko Kobayashi
Hiroshi Watanabe
Momoko Hazama
Takashi Kanno
Eiji Suzuki
Shiro Ishii
Kiyoshi Migita
Ohta Nishinouchi Hospital · JPFukushima Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionMulticentric reticulohistiocytosis (MRH) is a rare histiocytic disorder that involves the skin, joints, and visceral organs. CASE PRESENTATION: We report a 67-year-old woman with MRH who presented with a 2-years history of polyarthralgia and skin nodules. Her symptoms were an inflammatory polyarthropathy with punched-out lesions of the distal interphalangeal (DIP) joints of both hands. Doppler ultrasonography of the hands showed large bone erosions with power Doppler signals in the DIP joints. F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) demonstrated increased FDG uptake in cutaneous papules surrounding the affected joints, suggesting an inflammatory process. There was no evidence of malignancy. Biopsy samples of skin nodules exhibited dermal infiltration with CD68-positive histiocytes and multinucleated giant cells. The patient was diagnosed with MRH and treated with combination therapy comprising a steroid (prednisolone), tacrolimus, methotrexate, and infliximab, which resulted in clinical improvement. Following infliximab treatment, there was a significant decrease in a bone resorption marker (tartrate-resistant acid phosphatase 5b: TRACP-5b), suggesting that tumor necrosis factor-α targeting therapy may inhibit osteoclast formation and resorption activity in patients with MRH.

conclusionMRH is a progressive destructive arthritic condition, and early diagnostic and therapeutic strategies are necessary to improve the outcome. FDG-PET/CT and joint ultrasonography might be noninvasive imaging modalities that could help diagnose MRH.

Indexed as

AgedAntigens, CDAntigens, Differentiation, MyelomonocyticAntirheumatic AgentsArthralgiaAsian PeopleCD68 MoleculeDrug CombinationsFemaleFluorodeoxyglucose F18GlucocorticoidsHandHistiocytesHistiocytosis, Non-Langerhans-CellHumansImmunosuppressive AgentsAntigens, CDAntigens, Differentiation, MyelomonocyticAntirheumatic AgentsCD68 antigen, humanCD68 MoleculeDrug CombinationsFluorodeoxyglucose F18GlucocorticoidsImmunosuppressive AgentsInfliximabMethotrexatePrednisoloneTacrolimusTumor Necrosis Factor-alpha

Identifiers

PMID30113451
PMCPMC6112898
OpenAlexW2885967462

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.